Parallax Volatility Advisers
IMMU

Parallax Volatility Advisers’s Immunomedics Inc IMMU Stock Holding History

Parallax Volatility Advisers’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-23
Closed -$1K – 3265
2020
Q2 		$1K Buy
+23
New +$672 ﹤0.01% 2670
2019
Q4 		– Sell
-1,377
Closed -$24.3K – 2766
2019
Q3 		$18K Sell
1,377
-14,617
-91% -$215K ﹤0.01% 2158
2019
Q2 		$222K Buy
+15,994
New +$241K ﹤0.01% 1702
2019
Q1 		– Sell
-229,702
Closed -$3.7M – 4430
2018
Q4 		$3.28M Buy
229,702
+73,823
+47% +$1.47M ﹤0.01% 858
2018
Q3 		$3.25M Buy
155,879
+2,157
+1% +$51.1K ﹤0.01% 870
2018
Q2 		$3.64M Buy
153,722
+142,630
+1,286% +$2.87M 0.01% 719
2018
Q1 		$162K Sell
11,092
-27,369
-71% -$447K ﹤0.01% 1289
2017
Q4 		$622K Buy
38,461
+18,599
+94% +$220K ﹤0.01% 1398
2017
Q3 		$278K Sell
19,862
-259,847
-93% -$2.59M ﹤0.01% 1387
2017
Q2 		$2.47M Buy
+279,709
New +$1.96M ﹤0.01% 771

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Parallax Volatility Advisers's IMMU Position: Q3 2020 in Review

Parallax Volatility Advisers sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 23 shares — an estimated $1K sold.

Parallax Volatility Advisers first reported a position in IMMU in Q2 2017 and held it in 10 quarters. The position peaked at $3.64M in Q2 2018. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Parallax Volatility Advisers reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • Parallax Volatility Advisers sold 23 Immunomedics Inc shares in Q3 2020, an estimated $1K.
  • Parallax Volatility Advisers first reported a position in Immunomedics Inc in Q2 2017 and held it in 10 quarters.
  • Parallax Volatility Advisers's Immunomedics Inc position peaked at $3.64M in Q2 2018.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Parallax Volatility Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.